Tandem Diabetes Care, Inc. (TNDM) key performance indicators and operating metrics (11 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 2.73M | FY2026-Q1 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization Margin | 1.00 percent | FY2026-Q1 |
| Non-Generally Accepted Accounting Principles Operating Margin | 7.00 percent | FY2026-Q1 |
| Pump Shipments Worldwide | 29K | FY2026-Q1 |
| Gross Margin (Non-Generally Accepted Accounting Principles) | 58.00 percent | FY2025-Q4 |
| United States Pump Shipments | 27K | FY2025-Q4 |
| Gross Profit (Non-Generally Accepted Accounting Principles) | 134.3M | FY2025-Q3 |
| Operating Loss (Non-Generally Accepted Accounting Principles) | 22.9M | FY2025-Q3 |
| Pump Shipments in the United States | 20K | FY2025-Q3 |
| Net Loss (Non-Generally Accepted Accounting Principles) | 32.4M | FY2025-Q2 |
| Worldwide Non-Generally Accepted Accounting Principles Sales | 252.4M | FY2024-Q4 |
Back to TNDM overview · TNDM earnings · TNDM holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.